SpaceX Scrubs Starship Test Flight Hours After Releasing IPO Prospectus Retry Scheduled for Friday APEC Talks Highlight Persistent USChina Trade Gaps Three Key Signs Major Tech and Chip Companies Invest 125 Million in UCLA Semiconductor Research Hub AIs Growing Influence on Quarterly Earnings Reports A Broad Market Perspective Amazon Stock Exploring Income Generation Strategies for Bullish Investors UKGulf Trade Deal Bahrain Minister Hails Monumental Achievement in Bilateral Relations CNTY Q1 2026 Earnings EPS Beats Estimates Despite Continued Loss CMS Energy Q1 2026 Earnings Solid EPS Beat Driven by Regulatory Tailwinds and Operational Efficiency Plexus Corp PLXS Q1 2026 Earnings Solid EPS Beat Partially Offset by Cautious Market Sentiment SVRA Q1 2026 Earnings EPS Misses Estimates as PreRevenue Biotech Continues Development EVgo Q1 2026 Earnings Narrower Loss Beats Expectations Amid Steady Operational Progress WNC Q1 2026 Earnings EPS Falls Sharply Below Expectations as Operational Headwinds Persist XOMA Royalty Preferred Stock XOMAP Holds Steady Near 2545 Amid Low Volatility Alliance Resource Partners ARLP Moves Higher as Support Holds Firm Soren Acquisition Corp Warrants SORNW Edge Higher as Support Levels Hold Global Net Lease GNL Edges Lower as Price Hovers Near Key Support Uranium Energy Corp Gains 225 as Nuclear Sentiment Strengthens Inflation Reacceleration Broadens Beyond Oil Rising Costs in Rent Food and Services TransMedics Q1 2026 Earnings EPS Misses Estimates by 52 as Revenue Data Unavailable Forgent Power Solutions Inc FPS Faces Resistance Slipping 128 Amid Cautious Trading CIM Q1 2026 Earnings Modest EPS Beat as Interest Rate Dynamics Shape Performance Femasys Inc FEMY Q1 2026 Earnings EPS Beat Drives 2985 Stock Surge AFYA Q1 2026 Earnings EPS Misses Estimates Stock Gains 218 FibroBiologics FBLG Q1 2026 Earnings Narrow EPS Miss as PreRevenue Biotech Continues RD Investment ELTX Q1 2026 Earnings EPS Misses Estimates as ClinicalStage Biotech Advances Pipeline GENI Q1 2026 Earnings Missed EPS Estimates but Stock Rallies on Market Optimism CYTK Q1 2026 Earnings NarrowerThanExpected Loss as Aficamten NDA Awaits FDA Review